Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia

Blood

Volumn 87, Issue 11, 1996, Pages 4789-4796

  Miyamoto, Toshihiro ^a   Nagafuji, Koji ^b   Akashi, Koichi ^b   Harada, Mine ^b   Kyo, Taiichi ^b   Akashi, Tomoyuki ^b   Takenaka, Katsuto ^b   Mizuno, Shin Ichi ^b   Gondo, Hisashi ^b   Okamura, Takashi ^b   Dohy, Hiroo ^b   Niho, Yoshiyuki ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER REGRESSION; CHROMOSOME MOSAICISM; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMOGENESIS; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 9344257318     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.11.4789.bloodjournal87114789     Document Type: Article

References (45)

1. Fourth International Workshop on Chromosomes in Leukemia, 1982: Translocation (8;21) (q22;q22) in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 11:284, 1984
2. Mitelman F, Heim S: Quantitative acute leukemia cytogenetics. Genes Chromosom Cancer 5:57, 1992
3. Gao J, Erickson P, Gardiner K, Le Beau MM, Diaz MO, Patterson D, Rowley JD, Drabkin HA: Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21) (q22;q22.3) in acute mylogenous leukemia. Proc Natl Acad Sci USA 88:4882, 1991
4. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M: t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 88:10431, 1991
5. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H: Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80:1825, 1992
6. Shimizu K, Miyoshi H, Kozu T, Nagata J, Enomoto K, Maseki N, Kaneko Y, Ohki M: Consistent disruption of the AML1 gene occurs within a single intron in the t(8;21) chromosomal translocation. Cancer Res 52:6945, 1992
7. Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko N, Asou H, Kamada N, Ohki M: Junctions of the AML1/MTG8 (ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 82:1270, 1993
8. Downing JR, Head DR, Curcio-Brint AM, Hulshof MG, Motroni TA, Raimondi SC, Carroll AJ, Drabkin HA, Willman C, Theil KS, Civin CI, Erickson P: An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the t(8;21) (q22;q22) translocation. Blood 81:2860, 1993
9. Bitter MA, LeBeau MM, Rowley JD, Larson RA, Golomb HM, Vardiman JW: Association between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol 18:211, 1987
10. Swirsky DM, Li YS, Matthews JG, Flemans RJ, Rees JKH, Hayhoe FGJ: 8;21 translocation in acute granulocytic leukaemia: Cytological, cytochemical and clinical features. Br J Haematol 56:199, 1984
11. Miyamoto T, Nagafuji K, Harada M, Eto T, Fujisaki T, Kubota A, Akashi K, Mizuno S, Takenaka K, Kanaji T, Gondo H, Okamura T, Inaba S, Niho Y: Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia. Br J Haematol 91:132, 1995
12. Nucifora G, Larson RA, Rowley JD: Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 82:712, 1993
13. Kusec R, Laczika K, Knobl P, Friedl J, Greinix H, Kahls P, Linkesch W, Schwarzinger I, Mitterbauer G, Purtscher B, Haas OA, Lechner K, Jaeger U: AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 8:735, 1994
14. Chang KS, Fan YH, Staas SA, Estey EH, Wang G, Trujillo JM, Erickson P, Drabkin H: Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Oncogene 8:983, 1993
15. Maruyama F, Staas SA, Estey EH, Cork A, Hirano M, Ino T, Freireich EJ, Yang P, Chang KS: Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia 8:40, 1994
16. Guerrasaio A, Rosso C, Martinelli G, Lo Coco F, Pampinella M. Santoro A, Lanza C, Allione B, Resegotti L, Saglio G: Polyclonal haemopoiesis associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continuous clinical remission. Br J Haematol 90:364, 1995
17. Lo Coco F, Diverio D, Pandolfi PP, Biondi A, Rossi V, Avvisati G, Rambaldi A, Arcese W, Petti MC, Meloni G, Mandelli F, Grignani F, Masera G, Barbui T, Pelicci PG: Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia. Lancet 340:1437, 1992
18. Miller WH Jr, Kakizuka A, Frankel SR, Warrell RP Jr, DeBlasio A, Levine K, Evans RM, Dmitrovsky E: Reverse transcription polymerase chain reaction for the rearranged retinoic acid alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proc Natl Acad Sci USA 89:2694, 1992
19. Diverio D, Pandolfi PP, Biondi A, Avvisati G, Petti MC, Mandelli F, Pelicci PG, Lo Coco F: Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission. Blood 82:3556, 1993
20. Turhan AG, Lemoine FM, Debert C, Bonnet ML, Baillou C, Picard F, Macintyre EA, Varet B: Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood 85:2154, 1995
21. Kyo T, Dohy H: Treatment of acute nonlymphocytic leukemia with alternating non-cross-resistant chemotherapy. Acta Haematol Jpn 51:1641, 1988
22. Teshima T, Harada M, Takamatsu Y, Makino K, Taniguchi S, Inaba S, Kondo S, Tanaka T, Akashi K, Minamishima I, Ishii E, Nishimura J, Niho Y: Cytotoxic drug and cytotoxic drug/G-CSF mobilization of peripheral blood stem cells and their use for autografting. Bone Marrow Transplant 10:215, 1992
23. Nagafuji K, Harada M, Teshima T, Eto T, Takamatsu Y, Okamura T, Murakawa M, Akashi K, Niho Y: Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type 1. Blood 82:2823, 1993
24. - blasts from acute myelogenous leukemia. Blood 78:197, 1991
25. Teramura M, Katahira J, Hoshino S, Motoji T, Oshimi K, Mizoguchi H: Clonal growth of human megakaryocyte progenitors in serum-free cultures: Effect of recombinant human interleukin 3. Exp Hematol 16:843, 1988
26. Takamatsu Y, Harada M, Teshima T, Makino S, Inaba S, Akashi K, Shibuya T, Niho Y: Relationship of infused CFU-GM and CFU-Mk mobilized by chemotherapy with or without G-CSF to platelet recovery after autologous blood stem cell transplantation. Exp Hematol 23:8, 1995
27. Chomczynski P and Sacchi N: Single step methods of RNA isolation by acid guanidine thiocyanate phenol chloroform extraction. Anal Biochem 162:156, 1987
28. Asou H, Tashiro S, Hamamoto K, Otuji A, Kita K, Kamada N: Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 77:2031, 1991
29. Crutchley DJ, Conanan LB, Que BG: Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-α and interleukin-1β in human monocytic THP-1 cells. J Pharmacol Exp Ther 271:446, 1994
30. Kwok S, Higuchi R: Avoiding false positive with PCR. Nature 339:237, 1989
31. Gilliland DG, Blanchard KL, Levy J, Perrin S, Bunn HF: Clonality in myeloproliferative disorders: Analysis by means of the polymerase chain reaction. Proc Natl Acad Sci USA 88:6848, 1991
32. Fialkow PJ, Singer JW, Raskind WH, Adamson JW, Jacobson RJ, Bernstein ID, Dow LW, Najfeld V, Veith R: Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia. N Engl J Med 317:468, 1987
33. Sakakura C, Yamuguchi-Iwai Y, Satake M, Bae SC, Takahashi A, Ogawa E, Hagiwara A, Takahashi T, Murakami A, Makino K, Nakagawa T, Kamada N, Itoh Y: Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8 (ETO)-specific antisense oligonucleotide. Proc Natl Acad Sci USA 91:11723, 1994
34. Nucifora G, Dickstein JI, Torbenson V, Roulston D, Rowley JD, Vardiman JW: Correlation between cell morphology and expression of the AML1/ETO chimeric transcript in patients with acute myeloid leukemia without the t(8;21). Leukemia 8:1533, 1994
35. Golde DW, Champlin RE: Chronic myelogenous leukemia: Recent advances. Blood 65:1039, 1985
36. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M: Chronic myelogenous leukemia: A concise update. Blood 82:691, 1993
37. Akashi K, Mizuno S, Harada M, Kimura N, Kinjyo M, Shibuya T, Shimoda K, Takeshita M, Okamura S, Matsumoto I, Kikuchi M, Niho Y: T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia. Exp Hematol 21:743, 1993
38. Sadamura S, Umemura T, Takahira H, Hirata J, Nishimura J, Nawata H: Analysis of clonality at the level of progenitors in chronic myelogenous leukemia using the polymerase chain reaction. Leuk Res 16:371, 1992
39. Dexter TM, Chang J: New strategies for the treatment of chronic myeloid leukemia. Blood 84:673, 1994
40. Delfau MH, Kerckaert JP, d'Hooghe MC, Fenaux P, Lai JL, Jouet JP, Grandchamp B: Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Leukemia 4:1, 1990
41. Hughes T, Morgan GJ, Martiat P, Goldman JM: Detection of residual leukemia after bone marrow transplantation for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood 77:874, 1991
42. Lee MS, Kantarjian H, Talpaz M, Freireich FJ, Deisseroth A, Trujillo JM, Stass SA: Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy. Blood 79:1920, 1992
43. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N: Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21) (q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80:470, 1992
44. Gale RP, Ben-Bassat I: Hybrid acute leukaemia. Br J Haematol 65:261, 1987
45. Akashi K, Shibuya T, Harada M, Morioka E, Oshima K, Kimura N, Takeshita M, Kurokawa M, Kikuchi M, Niho Y: Acute 'bilineal-biphenotypic' leukemia. Br J Haematol 74:402, 1990